Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Phase II trial of trimodality therapy for malignant pleural mesothelioma (EORTC 08031)

P.E. Van Schil, P. Baas, R. Gaafar, A.P. Maat, M. van de Pol, B. Hasan, H.M. Klomp, A.M. Abdelrahman, J. Welch, J. Van Meerbeeck on behalf of the EORTC Lung Cancer Group
European Respiratory Journal 2010; DOI: 10.1183/09031936.00039510
P.E. Van Schil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: paul.van.schil@uza.be
P. Baas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Gaafar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.P. Maat
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. van de Pol
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Hasan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.M. Klomp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.M. Abdelrahman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Welch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Van Meerbeeck
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1183/09031936.00039510
PubMed 
20525721

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online June 4, 2010.

Article Versions

  • You are currently viewing a previous version of this article (June 4, 2010 - 00:54).
  • View the most recent version of this article
Copyright & Usage 
ERS

Author Information

  1. P.E. Van Schil*,
  2. P. Baas#,
  3. R. Gaafar¶,
  4. A.P. Maat+,
  5. M. van de Pol§,
  6. B. Hasanf,
  7. H.M. Klomp**,
  8. A.M. Abdelrahman¶,
  9. J. Welchf,
  10. J. Van Meerbeeck** and
  11. on behalf of the EORTC Lung Cancer Group
  1. *Antwerp University Hospital Belgium
  2. #Netherlands Cancer Institute Amsterdam the Netherlands
  3. ¶National Cancer Institute, Cairo University Egypt
  4. +Erasmus University Rotterdam the Netherlands
  5. §Dr. Bernard Verbeelen Institute Tilburg the Netherlands
  6. **EORTC Data Center Brussels, Belgium
  7. ##Lung Oncological Network Ghent (LONG), Ghent University Hospital Belgium
  1. P.E. Van Schil, Dept of Thoracic and Vascular Surgery, Antwerp University Hospital, Wilrijkstraat 10, B-2650 Edegem (Antwerp), Belgium E-mail: paul.van.schil{at}uza.be

Article usage

Article usage: June 2010 to April 2022

AbstractFullPdf
Jun 201073049
Jul 201023021
Aug 201070046
Sep 2010108062
Oct 201058051
Nov 2010136446
Dec 201014102896
Jan 20114411640
Feb 20112801319
Mar 20112112533
Apr 20111411426
May 2011132911
Jun 20117777
Jul 2011801114
Aug 20116037
Sep 201166117
Oct 2011831115
Nov 201152812
Dec 2011481020
Jan 201256623
Feb 201274914
Mar 2012891225
Apr 201266614
May 201278816
Jun 2012421526
Jul 2012331426
Aug 2012372754
Sep 2012481435
Oct 2012442939
Nov 2012383025
Dec 2012303435
Jan 2013473433
Feb 2013402036
Mar 2013393530
Apr 2013302932
May 2013253136
Jun 2013342124
Jul 2013211017
Aug 2013261017
Sep 2013282315
Oct 2013221916
Nov 2013582225
Dec 2013451712
Jan 2014162214
Feb 2014241324
Mar 2014251715
Apr 2014262112
May 2014372022
Jun 2014161919
Jul 201427117
Aug 2014231923
Sep 2014241430
Oct 2014221420
Nov 2014341840
Dec 201414722
Jan 2015181522
Feb 2015131210
Mar 2015292831
Apr 2015173230
May 2015222013
Jun 2015192421
Jul 201592217
Aug 2015142319
Sep 2015292721
Oct 201572418
Nov 201592017
Dec 201532211
Jan 201652322
Feb 201643019
Mar 2016124859
Apr 201631921
May 201642415
Jun 2016173231
Jul 201682612
Aug 201643435
Sep 2016182831
Oct 2016122315
Nov 201663334
Dec 201662417
Jan 2017122823
Feb 201782610
Mar 201784115
Apr 201753311
May 2017223431
Jun 201771512
Jul 201710269
Aug 201754812
Sep 2017103613
Oct 2017122514
Nov 201753113
Dec 20176135
Jan 20188278
Feb 201892920
Mar 2018133110
Apr 20189327
May 201815293
Jun 2018204710
Jul 201823266
Aug 201825289
Sep 20185215
Oct 201843013
Nov 201811288
Dec 20181237
Jan 20193222
Feb 20191278
Mar 201922910
Apr 201932119
May 20191159
Jun 20191166
Jul 201982511
Aug 201933415
Sep 201938123
Oct 201921611
Nov 201923113
Dec 201911710
Jan 202042418
Feb 20201247
Mar 20200166
Apr 20201129
May 202012412
Jun 202023018
Jul 202003317
Aug 20205209
Sep 202023713
Oct 2020103116
Nov 202042313
Dec 20208377
Jan 202152321
Feb 202123415
Mar 202163412
Apr 202164216
May 2021105020
Jun 202192912
Jul 20211214221
Aug 2021232810
Sep 202152910
Oct 202195534
Nov 2021132338
Dec 2021162816
Jan 202283625
Feb 202231912
Mar 20224244
Apr 2022123011

Altmetrics

Next
Back to top
Vol 59 Issue 5 Table of Contents
European Respiratory Journal: 59 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phase II trial of trimodality therapy for malignant pleural mesothelioma (EORTC 08031)
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Phase II trial of trimodality therapy for malignant pleural mesothelioma (EORTC 08031)
P.E. Van Schil, P. Baas, R. Gaafar, A.P. Maat, M. van de Pol, B. Hasan, H.M. Klomp, A.M. Abdelrahman, J. Welch, J. Van Meerbeeck
European Respiratory Journal Jan 2010, erj00395-2010; DOI: 10.1183/09031936.00039510

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Phase II trial of trimodality therapy for malignant pleural mesothelioma (EORTC 08031)
P.E. Van Schil, P. Baas, R. Gaafar, A.P. Maat, M. van de Pol, B. Hasan, H.M. Klomp, A.M. Abdelrahman, J. Welch, J. Van Meerbeeck
European Respiratory Journal Jan 2010, erj00395-2010; DOI: 10.1183/09031936.00039510
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary pharmacology and therapeutics
  • Lung cancer
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Umeclidinium in patients with COPD
  • EBUS-guided cryobiopsies in peripheral pulmonary lesions
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society